Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taisuke Ueda

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Intervirology|June 27, 2008
Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, SonazoidKinuyo Hatanaka, Masatoshi Kudo, Yasunori Minami, et al.
Oncology|December 22, 2007
Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic imagesYasunori Minami, Masatoshi Kudo, Hobyung Chung, et al.
Intervirology|January 14, 2010
PEG-IFNalpha/RBV combination therapy for chronic hepatitis C patients increases serum ferritin level while it improves sustained viral response rateNorihisa Yada, Masatoshi Kudo, Hobyung Chung, et al.
Oncology|July 10, 2010
Hepatic arterial infusion chemotherapy using low-dose 5-fluorouracil and cisplatin for advanced hepatocellular carcinomaKazuomi Ueshima, Masatoshi Kudo, Masahiro Takita, et al.
Oncology|December 19, 2008
Combination therapy with S-1 and pegylated interferon alpha for advanced hepatocellular carcinomaKazuomi Ueshima, Masatoshi Kudo, Tomoyuki Nagai, et al.
Digestion|December 14, 2011
Association of interleukin-28B and hepatitis C genotype 1 with a high viral load and response to pegylated interferon plus ribavirin therapyMasahiro Takita, Satoru Hagiwara, Tadaaki Arizumi, et al.
Oncology|July 10, 2010
Radiofrequency ablation for hepatocellular carcinoma: assistant techniques for difficult casesTatsuo Inoue, Yasunori Minami, Hobyung Chung, et al.
Digestive Diseases (Basel, Switzerland)|August 11, 2011
Des-γ-carboxyprothrombin may be a promising biomarker to determine the therapeutic efficacy of sorafenib for hepatocellular carcinomaKazuomi Ueshima, Masatoshi Kudo, Masahiro Takita, et al.
Digestive Diseases (Basel, Switzerland)|December 22, 2012
Retreatment with peginterferon α-2a + ribavirin in patients who failed previous peginterferon α-2b + ribavirin combination therapyTaisuke Ueda, Kaoru Tsuchiya, Satoru Hashimoto, et al.
Oncology|December 19, 2008
Response evaluation of transcatheter arterial chemoembolization in hepatocellular carcinomas: the usefulness of sonazoid-enhanced harmonic sonographyYu Xia, Masatoshi Kudo, Yasunori Minami, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Intervirology|June 27, 2008
Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, SonazoidKinuyo Hatanaka, Masatoshi Kudo, Yasunori Minami, et al.
Oncology|December 22, 2007
Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic imagesYasunori Minami, Masatoshi Kudo, Hobyung Chung, et al.
Intervirology|January 14, 2010
PEG-IFNalpha/RBV combination therapy for chronic hepatitis C patients increases serum ferritin level while it improves sustained viral response rateNorihisa Yada, Masatoshi Kudo, Hobyung Chung, et al.
Oncology|July 10, 2010
Hepatic arterial infusion chemotherapy using low-dose 5-fluorouracil and cisplatin for advanced hepatocellular carcinomaKazuomi Ueshima, Masatoshi Kudo, Masahiro Takita, et al.
Oncology|December 19, 2008
Combination therapy with S-1 and pegylated interferon alpha for advanced hepatocellular carcinomaKazuomi Ueshima, Masatoshi Kudo, Tomoyuki Nagai, et al.
Digestion|December 14, 2011
Association of interleukin-28B and hepatitis C genotype 1 with a high viral load and response to pegylated interferon plus ribavirin therapyMasahiro Takita, Satoru Hagiwara, Tadaaki Arizumi, et al.
Oncology|July 10, 2010
Radiofrequency ablation for hepatocellular carcinoma: assistant techniques for difficult casesTatsuo Inoue, Yasunori Minami, Hobyung Chung, et al.
Digestive Diseases (Basel, Switzerland)|August 11, 2011
Des-γ-carboxyprothrombin may be a promising biomarker to determine the therapeutic efficacy of sorafenib for hepatocellular carcinomaKazuomi Ueshima, Masatoshi Kudo, Masahiro Takita, et al.
Digestive Diseases (Basel, Switzerland)|December 22, 2012
Retreatment with peginterferon α-2a + ribavirin in patients who failed previous peginterferon α-2b + ribavirin combination therapyTaisuke Ueda, Kaoru Tsuchiya, Satoru Hashimoto, et al.
Oncology|December 19, 2008
Response evaluation of transcatheter arterial chemoembolization in hepatocellular carcinomas: the usefulness of sonazoid-enhanced harmonic sonographyYu Xia, Masatoshi Kudo, Yasunori Minami, et al.
Pageof 3